Kriti Nutrients Limited (BOM:533210)
74.48
+0.67 (0.91%)
At close: Feb 12, 2026
Kriti Nutrients Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 8,663 | 7,343 | 6,844 | 7,969 | 7,529 | 6,901 |
Other Revenue | - | - | - | - | - | -0 |
| 8,663 | 7,343 | 6,844 | 7,969 | 7,529 | 6,901 | |
Revenue Growth (YoY) | 22.58% | 7.30% | -14.12% | 5.84% | 9.10% | 32.61% |
Cost of Revenue | 7,725 | 6,324 | 5,744 | 7,165 | 6,804 | 6,124 |
Gross Profit | 938.05 | 1,019 | 1,099 | 803.7 | 725.25 | 776.17 |
Selling, General & Admin | 235.97 | 237.99 | 208.9 | 154.19 | 141.63 | 128.07 |
Other Operating Expenses | 300.02 | 300.96 | 268.16 | 337.6 | 389.94 | 418.47 |
Operating Expenses | 592.98 | 593.35 | 523.97 | 533.42 | 568.91 | 580.7 |
Operating Income | 345.07 | 425.85 | 575.27 | 270.27 | 156.34 | 195.47 |
Interest Expense | -3.2 | -3.54 | -10.85 | -30.65 | -17.17 | -5.58 |
Interest & Investment Income | 53.06 | 53.06 | 29.14 | 19.03 | 13.32 | 16.15 |
Currency Exchange Gain (Loss) | 11.92 | 11.92 | 10.58 | 16.3 | 19.15 | -0.98 |
Other Non Operating Income (Expenses) | 6.1 | 0.71 | -0.15 | 4.38 | -2.81 | -3.26 |
EBT Excluding Unusual Items | 411.85 | 487.99 | 603.98 | 279.32 | 168.83 | 201.8 |
Gain (Loss) on Sale of Investments | 9.77 | 9.77 | 1.87 | - | -0.51 | 1.03 |
Pretax Income | 421.62 | 497.76 | 605.85 | 279.32 | 168.32 | 202.83 |
Income Tax Expense | 96.72 | 127.52 | 152.98 | 71.34 | 45.26 | 52.26 |
Net Income | 324.9 | 370.24 | 452.87 | 207.98 | 123.05 | 150.57 |
Net Income to Common | 324.9 | 370.24 | 452.87 | 207.98 | 123.05 | 150.57 |
Net Income Growth | -20.42% | -18.25% | 117.74% | 69.02% | -18.27% | -20.77% |
Shares Outstanding (Basic) | 50 | 50 | 50 | 50 | 50 | 50 |
Shares Outstanding (Diluted) | 50 | 50 | 50 | 50 | 50 | 50 |
EPS (Basic) | 6.49 | 7.39 | 9.04 | 4.15 | 2.46 | 3.01 |
EPS (Diluted) | 6.49 | 7.39 | 9.04 | 4.15 | 2.46 | 3.01 |
EPS Growth | -20.37% | -18.25% | 117.80% | 68.98% | -18.27% | -20.71% |
Free Cash Flow | - | 273.48 | 409.62 | 134.13 | -193.72 | 38.16 |
Free Cash Flow Per Share | - | 5.46 | 8.18 | 2.68 | -3.87 | 0.76 |
Dividend Per Share | - | 0.300 | 0.300 | 0.250 | 0.180 | 0.180 |
Dividend Growth | - | - | 20.00% | 38.89% | - | - |
Gross Margin | 10.83% | 13.88% | 16.06% | 10.09% | 9.63% | 11.25% |
Operating Margin | 3.98% | 5.80% | 8.41% | 3.39% | 2.08% | 2.83% |
Profit Margin | 3.75% | 5.04% | 6.62% | 2.61% | 1.63% | 2.18% |
Free Cash Flow Margin | - | 3.72% | 5.99% | 1.68% | -2.57% | 0.55% |
EBITDA | 401.9 | 476.18 | 616.93 | 307.82 | 188.18 | 224.22 |
EBITDA Margin | 4.64% | 6.49% | 9.01% | 3.86% | 2.50% | 3.25% |
D&A For EBITDA | 56.83 | 50.33 | 41.67 | 37.55 | 31.84 | 28.75 |
EBIT | 345.07 | 425.85 | 575.27 | 270.27 | 156.34 | 195.47 |
EBIT Margin | 3.98% | 5.80% | 8.41% | 3.39% | 2.08% | 2.83% |
Effective Tax Rate | 22.94% | 25.62% | 25.25% | 25.54% | 26.89% | 25.77% |
Revenue as Reported | 8,746 | 7,421 | 6,888 | 8,013 | 7,562 | 6,925 |
Advertising Expenses | - | 32.33 | 20.65 | 18.51 | 19.8 | 17.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.